Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zappala

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
International Journal of Clinical Practice|May 13, 2017
The 4Kscore blood test accurately identifies men with aggressive prostate cancer prior to prostate biopsy with or without DRE informationStephen M Zappala, Yan Dong, Vincent Linder, et al.
Reviews in Urology|February 4, 2016
The 4Kscore® Test Reduces Prostate Biopsy Rates in Community and Academic Urology PracticesBadrinath Konety, Stephen M Zappala, Dipen J Parekh, et al.
Urology|April 3, 2017
Rapid and Short-term Extracellular Matrix-mediated In Vitro Culturing of Tumor and Nontumor Human Primary Prostate Cells From Fresh Radical Prostatectomy TissueAshok C Chander, Michael S Manak, Jonathan S Varsanik, et al.
Urology|October 13, 2018
Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4)David Albala, Michael S Manak, Jonathan S Varsanik, et al.
European Urology|December 3, 2014
A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancerDipen J Parekh, Sanoj Punnen, Daniel D Sjoberg, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
International Journal of Clinical Practice|May 13, 2017
The 4Kscore blood test accurately identifies men with aggressive prostate cancer prior to prostate biopsy with or without DRE informationStephen M Zappala, Yan Dong, Vincent Linder, et al.
Reviews in Urology|February 4, 2016
The 4Kscore® Test Reduces Prostate Biopsy Rates in Community and Academic Urology PracticesBadrinath Konety, Stephen M Zappala, Dipen J Parekh, et al.
Urology|April 3, 2017
Rapid and Short-term Extracellular Matrix-mediated In Vitro Culturing of Tumor and Nontumor Human Primary Prostate Cells From Fresh Radical Prostatectomy TissueAshok C Chander, Michael S Manak, Jonathan S Varsanik, et al.
Urology|October 13, 2018
Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4)David Albala, Michael S Manak, Jonathan S Varsanik, et al.
European Urology|December 3, 2014
A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancerDipen J Parekh, Sanoj Punnen, Daniel D Sjoberg, et al.
Pageof 3